Capricor Therapeutics
CAPR
#6014
Rank
A$1.62 B
Marketcap
A$28.08
Share price
-0.71%
Change (1 day)
193.53%
Change (1 year)

Capricor Therapeutics (CAPR) - Cash on Hand

Cash on Hand as of March 2026 : A$0.39 Billion

According to Capricor Therapeutics 's latest financial reports the company has A$0.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Capricor Therapeutics - Cash on Hand chart (from 2001 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$0.47 B94.98%
2024-12-31A$0.24 B320.29%
2023-12-31A$57.95 M-4.78%
2022-12-31A$60.86 M26.5%
2021-12-31A$48.11 M13.27%
2020-12-31A$42.48 M200.88%
2019-12-31A$14.11 M37.07%
2018-12-31A$10.3 M-43.07%
2017-12-31A$18.09 M-19.47%
2016-12-31A$22.46 M20.64%
2015-12-31A$18.62 M89.7%
2014-12-31A$9.81 M325.93%
2013-12-31A$2.3 M-45.1%
2012-12-31A$4.19 M314.23%
2011-12-31A$1.01 M-69.53%
2010-12-31A$3.32 M-5.93%
2009-12-31A$3.53 M-54.66%
2008-12-31A$7.79 M-58.01%
2007-12-31A$18.56 M
2005-12-31A$0 M-53.2%
2004-12-31A$0 M-43.47%
2003-12-31A$0 M3171.4%
2002-12-31A$0 M-85.48%
2001-12-31A$0 M-98.7%
2000-12-31A$0.02 M
1999-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$31.50 B 7,814.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.88 B 372.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A$1.16 B 193.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.64 B 62.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$14.51 M-96.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$13.11 M-96.71%๐Ÿ‡บ๐Ÿ‡ธ USA